Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine
On Aug. 27, 2026, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) has approved…
-
-
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
On Mar. 23, 2026, Pfizer and Valneva announced topline results from the Phase 3 VALOR “Vaccine Against Lyme…
-
Lyme Disease Project announced at MIT
On Jan. 15, 2025, scientists from the Massachusetts Institute of Technology (MIT) announced the Lyme Alert Project. Vector…
-
New virus uncovered in China – increased threat of tick-borne diseases
On Oct. 11, 2024, researchers in China published a study that provided details about a new wetland virus….
-
Focus on Lyme announced launch of Lyme Disease Test with Over 90% Accuracy
On Sept. 19, 2024, the nonprofit organization Focus on Lyme and Aces Diagnostics announced a breakthrough in Lyme…
-
Biotechnology | Diagnostics | Infectious Disease | Non-Profit Research | Pharmaceutical | Therapeutics
Large-Scale Study Seeks to Unearth Causes of Persistent Symptoms of Lyme Disease
On Sept. 17, 2024, researchers from Tufts University announced they had received a $20.7 million grant from the…
-
international team of scientists announced mapping complete genetic makeup of Lyme disease-causing bacteria
On Aug. 14, 2024, an international team of scientists announced they had sequenced the complete genomes of the…
-
A protein found in human sweat may protect against Lyme disease
On Mar. 19, 2024, researchers at Massachusetts Institute of Technology (MIT) and the University of Helsinki have now…
-
Economic burden of Lyme disease could be nearly $1 billion annually in the U.S.
On May 23, 2022, a study reports the economic burden of Lyme disease could be nearly $1 billion…
-
Quidel received amended Emergency Use Authorization for new Sofia Q rapid antigen test device
On Jun. 11, 2021, Quidel announced today that it had received an amended Emergency Use Authorization (EUA) from…
-
TGen study predicted changing Lyme disease habitat across the West Coast
On Mar. 16, 2021, TGen announced a study that suggested ecosystems suitable for harboring ticks that carry debilitating…
-
Valneva and Pfizer announced a collaboration to co-develop and commercialize Lyme disease vaccine
On Apr. 30, 2020, Valneva and Pfizer announced a collaboration to develop and commercialize Valneva’s Lyme disease vaccine…
-
Lyme Bacterium Predates U.S. Lab That Conspiracy Theorists Say Unleashed Ticks on the Public
On Jul. 18, 2019, the U.S. House of Representatives last week voted to order the Department of Defense…
-
Ancient History of Lyme Disease in North America Revealed with Bacterial Genomes
On Aug. 28, 2017, a team of researchers led by the Yale School of Public Health announced they…
-
GlaxoSmithKline announced the company would no longer manufacture or distribute its Lyme disease vaccine
On Feb. 25, 2002, GlaxoSmithKline announced that the company would no longer manufacture or distribute its Lyme disease…
-
Lyme Disease Vaccine (Recombinant OspA) was licensed
On Dec. 21, 1998, the Lyme Disease Vaccine (Recombinant OspA), (LYMErix by SmithKline Beecham) was licensed for use…
-
CDC Launched National surveillance for Lyme disease
In 1992, the U.S. Centers for Disease Control and Prevention (CDC) launched a national surveillance for tick-borne Lyme…
-
Lyme Disease was identified and named
In 1981, researcher William Burgdorfer, Ph.D., at the National Institute for Allergy and Infectious Diseases (NIAID) Rocky Mountain…
